Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers
Status:
Recruiting
Trial end date:
2023-11-28
Target enrollment:
Participant gender:
Summary
This is a single centre, randomised, double-blind, placebo-controlled, multiple ascending
dose study of MEDI0618 in healthy male and female volunteers.
Subjects will receive MEDI0618 or placebo administered by intravenous infusion or
subcutaneous injection.
Safety, tolerability and pharmacokinetics of multiple ascending doses of MEDI0618 will be
assessed.